ReCode Therapeutics is set to secure up to $15m in additional funding from the Cystic Fibrosis Foundation to enhance its gene ...

A stunning forest of over 60 Christmas trees has transformed Wellington Airport into a festive wonderland, all in support of ...

"There is a grey cloud there, but there are ways of managing that grey cloud, there are ways to plan for it and there are ...

In our study population, 78.3% of the patients with CF and 87.1% of the parents had no preexisting knowledge of the availability of DTC genetic testing for carrier status of genetic diseases ...

"Spirovant Sciences doses first subject in cystic fibrosis gene therapy trial" was originally created and published by ...

The programme utilises Intellia’s CRISPR-based gene editing platform and DNA-writing technology. Credit: Natali _ Mis/Shutterstock. ReCode Therapeutics is set to secure up to $15m in additional ...

The firm's chief scientific officer called the achievement "a major milestone for Spirovant and for the cystic fibrosis ...

Rena Barrow has two sons with cystic fibrosis, born 20 years apart — but they faced the same terrible delay in diagnosis.

The Cystic Fibrosis Foundation is funding the development of a gene editing therapy that is designed to use ReCode’s tissue-specific delivery vehicle to transport gene editing cargo to the lung cells ...

BETHESDA, Md.--(BUSINESS WIRE)--The Cystic Fibrosis Foundation has agreed to invest up to $15 million in ReCode Therapeutics to support their gene editing collaboration with Intellia Therapeutics.